Pharma Journalist -

Exelixis announced that the U.S. Food and Drug Administration (FDA) approved CABOMETYX (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously…
Read More...

Key Pharmaceuticals Ltd to lead a workshop on Parallel Trade & Brexit during the 13th Annual Parallel Trade Conference SMi Group are delighted to have industry expert Tushar…
Read More...

Puma Biotechnology announced that it has entered into an exclusive License Agreement with Knight Therapeutics Inc. that grants Knight the exclusive right to commercialize NERLYNX…
Read More...

As China continues to advance from a big country in pharmaceuticals to a power in pharmaceuticals, and the global economy maintains good trends, the main business income of API…
Read More...

SAMDI Tech, Inc., the industry’s leading provider of label-free drug discovery solutions, has promoted Michael D. Scholle to chief operating officer. Formerly serving as director and…
Read More...

The bio-pharma industry has entered the new stage of rapid development in recent years with the continuous development of the cutting-edge biological technology and the emerging and…
Read More...

SIRION Biotech GmbH announced that it signed a license and collaboration agreement with Denali Therapeutics, a biopharmaceutical company developing a broad portfolio of product…
Read More...

SMi’s Pharma is proud to announce the 3rd Annual 3D Cell Culture is taking place at the Copthorne Tara Hotel in London, UK on 20th and 21st February 2019. Based on the recent article…
Read More...

Clinigen Group plc announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also…
Read More...

Selexis SA announced that it has signed additional commercial license agreements (CLAs) with Agenus, an immuno-oncology company with a pipeline of immune-modulating antibodies, cancer…
Read More...